Relay Therapeutics Inc
(NQ:
RLAY
)
6.240
-0.250 (-3.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
828,473
Open
6.500
Bid (Size)
6.500 (10)
Ask (Size)
6.960 (2)
Prev. Close
6.490
Today's Range
6.210 - 6.832
52wk Range
5.700 - 12.14
Shares Outstanding
121,613,181
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
September 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
September 05, 2024
The August ISM manufacturing index reported on Tuesday that figures came in below consensus expectation. That raised fears about the strength of the economy, driving down our Our AI-Focused Drug...
Via
Talk Markets
Topics
Economy
Exposures
Economy
Performance
YTD
-47.36%
-47.36%
1 Month
-8.24%
-8.24%
3 Month
-17.13%
-17.13%
6 Month
-34.32%
-34.32%
1 Year
-35.87%
-35.87%
More News
Read More
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
August 27, 2024
Via
Talk Markets
Expert Ratings For Relay Therapeutics
August 07, 2024
Via
Benzinga
RLAY Stock Earnings: Relay Therapeutics Beats EPS for Q2 2024
August 06, 2024
Via
InvestorPlace
Expert Ratings For Relay Therapeutics
July 17, 2024
Via
Benzinga
Expert Ratings For Relay Therapeutics
June 07, 2024
Via
Benzinga
Key Takeaways From Relay Therapeutics Analyst Ratings
May 10, 2024
Via
Benzinga
Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
August 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Announce Second Quarter 2024 Financial Results and Corporate Highlights on August 6, 2024
July 30, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
July 30, 2024
Via
Talk Markets
These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
July 24, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD
July 18, 2024
Via
Talk Markets
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
July 14, 2024
Via
Talk Markets
Clinical-Stage BioTech Drug Stocks Declined 13% In June
July 01, 2024
Via
Talk Markets
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
June 22, 2024
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
June 17, 2024
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
Via
Talk Markets
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
May 27, 2024
Via
Talk Markets
Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
5 Of 7 AI Categories Rose, Slightly,Over Past Week
May 11, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 7 AI Categories Declined, On Average, The First Week Of May
May 05, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.